Xu L, Si H, Zhuang F, Li C, et al. Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancer. J Thorac Cardiovasc Surg 2024 May 17:S0022-5223(24)00437.
PMID: 38763304